SPONSOR
National Institute of Cardiovascular Diseases, Pakistan
Total Trials
2
Recruiting
2
Phases
Phase 3
Conditions studied: Cardiogenic Shock Post Myocardial InfarctionAcute Myocardial Infarction of Anterior WallLeft Ventricular ThrombusProphylaxis
National Institute of Cardiovascular Diseases, Pakistan is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Cardiogenic Shock Post Myocardial Infarction, Acute Myocardial Infarction of Anterior Wall, Left Ventricular Thrombus, Prophylaxis.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — National Institute of Cardiovascular Diseases, Pakistan
How many clinical trials has National Institute of Cardiovascular Diseases, Pakistan sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by National Institute of Cardiovascular Diseases, Pakistan, of which 2 are actively recruiting participants. These trials cover conditions including Cardiogenic Shock Post Myocardial Infarction, Acute Myocardial Infarction of Anterior Wall, Left Ventricular Thrombus. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does National Institute of Cardiovascular Diseases, Pakistan research focus on?
National Institute of Cardiovascular Diseases, Pakistan clinical trials span Cardiogenic Shock Post Myocardial Infarction, Acute Myocardial Infarction of Anterior Wall, Left Ventricular Thrombus, Prophylaxis. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a National Institute of Cardiovascular Diseases, Pakistan clinical trial?
To participate in a National Institute of Cardiovascular Diseases, Pakistan trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all National Institute of Cardiovascular Diseases, Pakistan trials with current recruitment status updated daily.
Clinical Trials by National Institute of Cardiovascular Diseases, Pakistan
NCT07714746 Phase 3
Recruiting
Ivabradine in the Acute Management of Cardiogenic Shock
Cardiogenic Shock Post Myocardial Infarction
NCT06742567 Phase 3
Recruiting
Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction
Acute Myocardial Infarction of Anterior Wall
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology